Please assess the completion status of the following clinical trial:

Trial Title: A Multi-center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient is male or female and at least 18 years of age~* Female patients must be of either:~  * Non-childbearing potential, post-menopausal~ * Childbearing potential, provided there are negative serum and urine pregnancy test results prior to study treatment, to rule out pregnancy~Exclusion Criteria:~* Cosmetic or therapeutic procedures within 2 weeks and 2cm of the selected treatment area~* Treatment with immunomodulators, or interferon/ interferon inducers or systemic medications that suppress the immune system within 4 weeks~* Treatment with 5-FU, imiquimod, diclofenac, or photodynamic therapy: within 8 weeks and 2 cm of the selected treatment area

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- PEP005 gel (Type: EXPERIMENTAL): PEP005 gel, 0.015% applied once daily for three consecutive days
- Vehicle gel (Type: PLACEBO_COMPARATOR): Vehicle gel applied once daily for three consecutive days

Based on this trial design, predict the completion outcome and termination type (if applicable).